NICOLE VAUGHN: Open Payments
NPI 1023469202 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,108 in 82 payments from 16 companies in 2025. Trend: 2023 $876 · 2024 $744 · 2025 $3,108
Food & beverage: $1,941Travel & lodging: $1,168
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 11 | $1,540 |
| Otsuka America Pharmaceutical, Inc. | 19 | $437 |
| Alkermes, Inc. | 7 | $171 |
| Vanda Pharmaceuticals Inc. | 5 | $153 |
| Almatica Pharma LLC | 6 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $98 |
| Axsome Therapeutics, Inc. | 4 | $87 |
| Indivior Inc. | 3 | $87 |
| Neurocrine BioSciences, Inc. | 3 | $78 |
| Teva Pharmaceuticals USA, Inc. | 3 | $72 |
Products named: SPRAVATO, REXULTI, ARISTADA, FANAPT, LOREEV XR, TRINTELLIX, Auvelity, SUBLOCADE.
Industry payments across NV — which companies pay providers there.
